ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 264 filers reported holding ALKERMES PLC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,342 | -44.5% | 155 | -38.0% | 0.00% | – |
| Q2 2023 | $7,825 | -72.2% | 250 | -75.0% | 0.00% | – |
| Q1 2023 | $28,190 | +7.9% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $26,130 | +18.8% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $22,000 | -26.7% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $30,000 | +15.4% | 1,000 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | +116.7% | 1,000 | +100.0% | 0.00% | – |
| Q4 2021 | $12,000 | +200.0% | 500 | +151.3% | 0.00% | – |
| Q4 2019 | $4,000 | -98.4% | 199 | -98.5% | 0.00% | -100.0% |
| Q3 2019 | $252,000 | +25100.0% | 12,931 | +18112.7% | 0.01% | – |
| Q2 2019 | $1,000 | -98.7% | 71 | -96.0% | 0.00% | -100.0% |
| Q3 2018 | $75,000 | +31.6% | 1,767 | +28.2% | 0.00% | +33.3% |
| Q2 2018 | $57,000 | -9.5% | 1,378 | +24.8% | 0.00% | -25.0% |
| Q1 2018 | $63,000 | – | 1,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |